New wound therapy for rare skin disease shows early promise
NCT ID NCT05120726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a treatment for pyoderma gangrenosum, a rare skin condition that causes painful, hard-to-heal ulcers. Researchers used a special wound covering made from donated placenta tissue (EpiFix) followed by skin grafts. The study was stopped early after only 5 people enrolled, so we don't have strong results yet. The goal was to see if this approach could help wounds heal and reduce pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PYODERMA GANGRENOSUM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
LSU Healthcare Network Clinic
Metairie, Louisiana, 70006, United States
-
Ochsner Baptist Medical Center
New Orleans, Louisiana, 70115, United States
-
University Medical Center
New Orleans, Louisiana, 70112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New hope for painful skin ulcers: experimental drug enters human trials
- Can a psoriasis drug heal these stubborn skin ulcers?
- New injection aims to heal skin ulcers in rare disease
- Oxygen chamber therapy put to the test for dozens of diseases
- Promising drug trial for painful skin ulcers halted early
- New drug hopes to heal painful skin ulcers in rare disease